These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 24008407

  • 1. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
    Wiednig M, Beham-Schmid C, Kranzelbinder B, Aberer E.
    Dermatology; 2013; 227(1):67-71. PubMed ID: 24008407
    [Abstract] [Full Text] [Related]

  • 2. Mastocytosis: state of the art.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [Abstract] [Full Text] [Related]

  • 3. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L.
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [Abstract] [Full Text] [Related]

  • 4. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S, Flaig MJ, Ruëff F, Walz C, Haferlach T, Krokowski M, Kerler R, Petat-Dutter K, Horny HP, Sotlar K.
    Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
    [Abstract] [Full Text] [Related]

  • 5. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP, Hornick JL.
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [Abstract] [Full Text] [Related]

  • 6. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J, Wenzel J, Ko Y, Bieber T, Bauer R.
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [Abstract] [Full Text] [Related]

  • 7. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R, Butterfield J.
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [Abstract] [Full Text] [Related]

  • 8. Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.
    Reichard KK, Chen D, Pardanani A, McClure RF, Howard MT, Kurtin PJ, Wood AJ, Ketterling RP, King RL, He R, Morice WG, Hanson CA.
    Am J Clin Pathol; 2015 Sep; 144(3):493-502. PubMed ID: 26276780
    [Abstract] [Full Text] [Related]

  • 9. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA, Sepehr GJ, Hamilton MJ, Akin C, Castells MC, Hornick JL.
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [Abstract] [Full Text] [Related]

  • 10. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, Castellani L, Bonetto C, Frattini F, Dama A, Martinelli G, Chilosi M, Senna G, Pizzolo G, Zanotti R.
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [Abstract] [Full Text] [Related]

  • 11. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
    Escande H, Bennani I, Bulai Livideanu C, Uthurriague C, Paul C, Nougué J.
    Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
    [Abstract] [Full Text] [Related]

  • 12. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP.
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [Abstract] [Full Text] [Related]

  • 13. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [Abstract] [Full Text] [Related]

  • 14. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
    Jawhar M, Schwaab J, Horny HP, Sotlar K, Naumann N, Fabarius A, Valent P, Cross NC, Hofmann WK, Metzgeroth G, Reiter A.
    Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
    [Abstract] [Full Text] [Related]

  • 15. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
    Horny HP, Sotlar K, Sperr WR, Valent P.
    J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
    [Abstract] [Full Text] [Related]

  • 16. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
    Pardanani A.
    Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
    [Abstract] [Full Text] [Related]

  • 17. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M, Żawrocki A, Nedoszytko B, Wasąg B, Niedoszytko M, Jassem E, Nowicki R, Żmijewski MA, Biernat W.
    Int Arch Allergy Immunol; 2014 Jul; 165(2):104-10. PubMed ID: 25402852
    [Abstract] [Full Text] [Related]

  • 18. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
    Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB, Mastocytosis Centre Odense University Hospital (MastOUH).
    Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.
    Klion AD, Noel P, Akin C, Law MA, Gilliland DG, Cools J, Metcalfe DD, Nutman TB.
    Blood; 2003 Jun 15; 101(12):4660-6. PubMed ID: 12676775
    [Abstract] [Full Text] [Related]

  • 20. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP, Sotlar K, Valent P.
    Pathobiology; 2010 Jun 15; 77(4):169-80. PubMed ID: 20616612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.